TrialSleep2011

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Andrew D Krystal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.